- Home
- SQFT vs APTO Comparison
SQFT vs APTO Comparison
Compare SQFT & APTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SQFT
- APTO
- Stock Information
- Founded
- SQFT 1999
- APTO 1986
- Country
- SQFT United States
- APTO Canada
- Employees
- SQFT N/A
- APTO N/A
- Industry
- SQFT Real Estate Investment Trusts
- APTO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SQFT Real Estate
- APTO Health Care
- Exchange
- SQFT Nasdaq
- APTO Nasdaq
- Market Cap
- SQFT 8.1M
- APTO 6.8M
- IPO Year
- SQFT 2020
- APTO N/A
- Fundamental
- Price
- SQFT $0.57
- APTO $1.71
- Analyst Decision
- SQFT
- APTO Strong Buy
- Analyst Count
- SQFT 0
- APTO 3
- Target Price
- SQFT N/A
- APTO $112.00
- AVG Volume (30 Days)
- SQFT 19.1K
- APTO 58.8K
- Earning Date
- SQFT 05-13-2025
- APTO 05-13-2025
- Dividend Yield
- SQFT N/A
- APTO N/A
- EPS Growth
- SQFT N/A
- APTO N/A
- EPS
- SQFT N/A
- APTO N/A
- Revenue
- SQFT $18,925,275.00
- APTO N/A
- Revenue This Year
- SQFT $23.63
- APTO N/A
- Revenue Next Year
- SQFT N/A
- APTO N/A
- P/E Ratio
- SQFT N/A
- APTO N/A
- Revenue Growth
- SQFT 7.31
- APTO N/A
- 52 Week Low
- SQFT $0.47
- APTO $1.35
- 52 Week High
- SQFT $1.21
- APTO $50.10
- Technical
- Relative Strength Index (RSI)
- SQFT 36.15
- APTO 26.12
- Support Level
- SQFT $0.54
- APTO $3.20
- Resistance Level
- SQFT $0.60
- APTO $3.43
- Average True Range (ATR)
- SQFT 0.03
- APTO 0.35
- MACD
- SQFT -0.00
- APTO -0.06
- Stochastic Oscillator
- SQFT 33.33
- APTO 13.69
About SQFT Presidio Property Trust Inc.
Presidio Property Trust Inc is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. The office, industrial and retail properties are located primarily in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California.
About APTO Aptose Biosciences Inc.
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.